BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36527824)

  • 1. Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastases.
    Woldmar N; Schwendenwein A; Kuras M; Szeitz B; Boettiger K; Tisza A; László V; Reiniger L; Bagó AG; Szállási Z; Moldvay J; Szász AM; Malm J; Horvatovich P; Pizzatti L; Domont GB; Rényi-Vámos F; Hoetzenecker K; Hoda MA; Marko-Varga G; Schelch K; Megyesfalvi Z; Rezeli M; Döme B
    ESMO Open; 2023 Feb; 8(1):100741. PubMed ID: 36527824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor.
    Radeczky P; Moldvay J; Fillinger J; Szeitz B; Ferencz B; Boettiger K; Rezeli M; Bogos K; Renyi-Vamos F; Hoetzenecker K; Hegedus B; Megyesfalvi Z; Dome B
    Pathol Oncol Res; 2021; 27():1609926. PubMed ID: 34629961
    [No Abstract]   [Full Text] [Related]  

  • 3. New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study.
    Klikovits T; Lohinai Z; Fábián K; Gyulai M; Szilasi M; Varga J; Baranya E; Pipek O; Csabai I; Szállási Z; Tímár J; Hoda MA; Laszlo V; Hegedűs B; Renyi-Vamos F; Klepetko W; Ostoros G; Döme B; Moldvay J
    Lung Cancer; 2018 Dec; 126():139-148. PubMed ID: 30527178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
    Zhang QH; Dai XH; Dai ZM; Cai YN
    Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of development of brain metastases according to the IASLC/ATS/ERS lung adenocarcinoma classification in locally advanced and metastatic disease.
    Arrieta O; Salas AA; Cardona AF; Díaz-García D; Lara-Mejía L; Escamilla I; García AP; Pérez EC; Raez LE; Rolfo C; Rosell R
    Lung Cancer; 2021 May; 155():183-190. PubMed ID: 33558063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis.
    Téglási V; Pipek O; Lózsa R; Berta K; Szüts D; Harkó T; Vadász P; Rojkó L; Döme B; Bagó AG; Tímár J; Moldvay J; Szállási Z; Reiniger L
    Clin Lung Cancer; 2019 Sep; 20(5):363-369.e2. PubMed ID: 31178388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immune gene expression signature distinguishes central nervous system metastases from primary tumours in non-small-cell lung cancer.
    Tsakonas G; Lewensohn R; Botling J; Ortiz-Villalon C; Micke P; Friesland S; Nord H; Lindskog M; Sandelin M; Hydbring P; Ekman S
    Eur J Cancer; 2020 Jun; 132():24-34. PubMed ID: 32325417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element.
    Matsumura M; Okudela K; Kojima Y; Umeda S; Tateishi Y; Sekine A; Arai H; Woo T; Tajiri M; Ohashi K
    PLoS One; 2016; 11(11):e0166795. PubMed ID: 27861549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune suppressive microenvironment in brain metastatic non-small cell lung cancer: comprehensive immune microenvironment profiling of brain metastases versus paired primary lung tumors (GASTO 1060).
    Li M; Hou X; Sai K; Wu L; Chen J; Zhang B; Wang N; Wu L; Zheng H; Zhang J; Mou Y; Chen L
    Oncoimmunology; 2022; 11(1):2059874. PubMed ID: 35402080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
    Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CPS1 in Cell Growth, Metabolism and Prognosis in LKB1-Inactivated Lung Adenocarcinoma.
    Çeliktas M; Tanaka I; Tripathi SC; Fahrmann JF; Aguilar-Bonavides C; Villalobos P; Delgado O; Dhillon D; Dennison JB; Ostrin EJ; Wang H; Behrens C; Do KA; Gazdar AF; Hanash SM; Taguchi A
    J Natl Cancer Inst; 2017 Mar; 109(3):1-9. PubMed ID: 28376202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L1 cell adhesion molecule high expression is associated with poor prognosis in surgically resected brain metastases from lung adenocarcinoma.
    Wang JW; Wang SQ; Wu ZY; Liu Q; Yuan Q; Cai HQ; Wan JH
    Clinics (Sao Paulo); 2022; 77():100040. PubMed ID: 35525225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.
    Xiao G; Li L; Tanzhu G; Liu Z; Gao X; Wan X; Xiao D; Chen L; Xia X; Zhou R
    J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36868569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.
    Han HS; Eom DW; Kim JH; Kim KH; Shin HM; An JY; Lee KM; Choe KH; Lee KH; Kim ST; Koo JH; Lee HC; Lee OJ
    Clin Lung Cancer; 2011 Nov; 12(6):380-6. PubMed ID: 21729655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of decreased GRK6 expression in lung adenocarcinoma.
    Yao S; Zhong L; Liu J; Feng J; Bian T; Zhang Q; Chen J; Lv X; Chen J; Liu Y
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2541-2549. PubMed ID: 27601164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of
    Chang JH; Lai TC; Yang PJ; Shih PC; Yang YC; Lee KL; Liu TC; Tsao TC; Yang SF; Chien MH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell RNA Sequencing Analysis Identifies Key Genes in Brain Metastasis from Lung Adenocarcinoma.
    Zhang Z; Cui F; Zhou M; Wu S; Zou Q; Gao B
    Curr Gene Ther; 2021; 21(4):338-348. PubMed ID: 33745433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival.
    Pocha K; Mock A; Rapp C; Dettling S; Warta R; Geisenberger C; Jungk C; Martins LR; Grabe N; Reuss D; Debus J; von Deimling A; Abdollahi A; Unterberg A; Herold-Mende CC
    Clin Cancer Res; 2020 May; 26(9):2231-2243. PubMed ID: 31953311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell transcriptome analysis demonstrates inter-patient and intra-tumor heterogeneity in primary and metastatic lung adenocarcinoma.
    Liu Y; Ye G; Huang L; Zhang C; Sheng Y; Wu B; Han L; Wu C; Dong B; Qi Y
    Aging (Albany NY); 2020 Nov; 12(21):21559-21581. PubMed ID: 33170151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic landscape of primary and metastatic brain tumors for heterogeneity discovery.
    Yang S; Zhou C; Zhang L; Xiong Y; Zheng Y; Bian L; Liu X
    Proteomics Clin Appl; 2024 Mar; 18(2):e2300010. PubMed ID: 37726528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.